Laurus Labs Ltd
NSE:LAURUSLABS
Balance Sheet
Balance Sheet Decomposition
Laurus Labs Ltd
Laurus Labs Ltd
Balance Sheet
Laurus Labs Ltd
| Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||
| Cash & Cash Equivalents |
232
|
354
|
162
|
5
|
6
|
1
|
3
|
485
|
754
|
457
|
1 389
|
995
|
|
| Cash |
0
|
2
|
2
|
2
|
2
|
1
|
3
|
485
|
539
|
193
|
1 218
|
911
|
|
| Cash Equivalents |
232
|
352
|
160
|
3
|
4
|
0
|
0
|
0
|
214
|
263
|
171
|
84
|
|
| Short-Term Investments |
0
|
0
|
0
|
17
|
1
|
1
|
1
|
0
|
4
|
25
|
24
|
0
|
|
| Total Receivables |
2 199
|
2 853
|
4 454
|
5 971
|
5 919
|
7 313
|
8 312
|
13 457
|
13 950
|
17 047
|
18 187
|
22 201
|
|
| Accounts Receivables |
1 949
|
2 851
|
4 449
|
5 676
|
5 706
|
7 099
|
7 914
|
13 061
|
13 542
|
15 804
|
16 629
|
20 072
|
|
| Other Receivables |
250
|
2
|
5
|
295
|
213
|
214
|
398
|
397
|
408
|
1 242
|
1 558
|
2 129
|
|
| Inventory |
3 281
|
4 755
|
4 871
|
5 090
|
5 848
|
6 819
|
9 052
|
15 755
|
17 603
|
16 848
|
18 454
|
19 365
|
|
| Other Current Assets |
36
|
641
|
539
|
315
|
703
|
495
|
754
|
1 052
|
1 139
|
265
|
319
|
762
|
|
| Total Current Assets |
5 748
|
8 604
|
10 027
|
11 398
|
12 476
|
14 630
|
18 121
|
30 749
|
33 446
|
34 617
|
38 350
|
43 323
|
|
| PP&E Net |
6 104
|
8 443
|
10 842
|
13 556
|
16 271
|
17 168
|
17 740
|
22 772
|
32 086
|
37 002
|
40 475
|
43 160
|
|
| PP&E Gross |
6 104
|
0
|
10 842
|
13 556
|
16 271
|
17 168
|
17 740
|
22 772
|
32 086
|
37 002
|
40 475
|
43 160
|
|
| Accumulated Depreciation |
1 224
|
0
|
834
|
1 840
|
3 048
|
4 645
|
6 457
|
8 380
|
10 786
|
13 651
|
17 285
|
21 109
|
|
| Intangible Assets |
47
|
61
|
64
|
79
|
72
|
121
|
98
|
93
|
108
|
129
|
190
|
193
|
|
| Goodwill |
3
|
0
|
0
|
97
|
97
|
97
|
97
|
2 463
|
2 463
|
2 463
|
2 463
|
2 463
|
|
| Note Receivable |
685
|
306
|
292
|
137
|
142
|
87
|
199
|
765
|
525
|
1 443
|
612
|
1 318
|
|
| Long-Term Investments |
0
|
156
|
78
|
243
|
273
|
328
|
372
|
457
|
911
|
499
|
1 240
|
2 333
|
|
| Other Long-Term Assets |
145
|
857
|
931
|
1 024
|
837
|
880
|
877
|
208
|
142
|
451
|
541
|
566
|
|
| Other Assets |
3
|
0
|
0
|
97
|
97
|
97
|
97
|
2 463
|
2 463
|
2 463
|
2 463
|
2 463
|
|
| Total Assets |
12 732
N/A
|
18 427
+45%
|
22 235
+21%
|
26 534
+19%
|
30 167
+14%
|
33 312
+10%
|
37 503
+13%
|
57 507
+53%
|
69 680
+21%
|
76 604
+10%
|
83 870
+9%
|
93 356
+11%
|
|
| Liabilities | |||||||||||||
| Accounts Payable |
2 275
|
2 649
|
2 779
|
3 216
|
3 773
|
5 532
|
6 683
|
12 745
|
11 735
|
7 107
|
10 512
|
9 771
|
|
| Accrued Liabilities |
20
|
40
|
46
|
74
|
71
|
105
|
134
|
148
|
200
|
201
|
248
|
293
|
|
| Short-Term Debt |
3 122
|
4 316
|
4 814
|
6 442
|
7 585
|
6 842
|
7 905
|
8 861
|
9 107
|
9 958
|
13 893
|
17 150
|
|
| Current Portion of Long-Term Debt |
0
|
849
|
866
|
730
|
797
|
930
|
1 033
|
1 401
|
2 300
|
2 205
|
3 277
|
3 410
|
|
| Other Current Liabilities |
1 693
|
138
|
333
|
745
|
841
|
831
|
1 168
|
1 415
|
3 468
|
4 853
|
3 192
|
4 773
|
|
| Total Current Liabilities |
7 109
|
7 993
|
8 837
|
11 208
|
13 069
|
14 239
|
16 924
|
24 572
|
26 810
|
24 323
|
31 123
|
35 397
|
|
| Long-Term Debt |
1 882
|
3 020
|
4 597
|
1 246
|
1 417
|
2 587
|
1 856
|
4 554
|
6 360
|
7 989
|
8 604
|
7 078
|
|
| Deferred Income Tax |
118
|
0
|
0
|
0
|
0
|
0
|
0
|
192
|
691
|
825
|
570
|
319
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
32
|
79
|
111
|
46
|
1 300
|
|
| Other Liabilities |
39
|
206
|
232
|
777
|
855
|
902
|
1 026
|
2 182
|
2 229
|
2 982
|
2 418
|
4 537
|
|
| Total Liabilities |
9 148
N/A
|
11 219
+23%
|
13 667
+22%
|
13 230
-3%
|
15 341
+16%
|
17 728
+16%
|
19 805
+12%
|
31 531
+59%
|
36 169
+15%
|
36 229
+0%
|
42 761
+18%
|
48 630
+14%
|
|
| Equity | |||||||||||||
| Common Stock |
778
|
821
|
824
|
1 058
|
1 060
|
1 064
|
1 069
|
1 073
|
1 075
|
1 077
|
1 078
|
1 079
|
|
| Retained Earnings |
1 641
|
2 312
|
3 642
|
5 478
|
6 964
|
7 729
|
9 800
|
18 019
|
25 527
|
32 327
|
33 049
|
36 543
|
|
| Additional Paid In Capital |
1 131
|
4 046
|
4 071
|
6 704
|
6 737
|
6 787
|
6 852
|
6 948
|
7 013
|
7 131
|
7 171
|
7 328
|
|
| Other Equity |
34
|
29
|
32
|
66
|
65
|
4
|
24
|
64
|
11
|
39
|
27
|
225
|
|
| Total Equity |
3 584
N/A
|
7 209
+101%
|
8 568
+19%
|
13 304
+55%
|
14 826
+11%
|
15 584
+5%
|
17 698
+14%
|
25 976
+47%
|
33 512
+29%
|
40 375
+20%
|
41 110
+2%
|
44 726
+9%
|
|
| Total Liabilities & Equity |
12 732
N/A
|
18 427
+45%
|
22 235
+21%
|
26 534
+19%
|
30 167
+14%
|
33 312
+10%
|
37 503
+13%
|
57 507
+53%
|
69 680
+21%
|
76 604
+10%
|
83 870
+9%
|
93 356
+11%
|
|
| Shares Outstanding | |||||||||||||
| Common Shares Outstanding |
529
|
529
|
529
|
529
|
530
|
532
|
535
|
537
|
537
|
539
|
539
|
539
|
|